Magnus Ingelman-Sundberg#


Magnus Ingelman-Sundberg
Email:magnus.ingelman-sundberg 'at' ki.se
Membership Number:4540
Membership type:ORDINARY
Main Country of Residence:SWEDEN
Section:CLINICAL & VETERINARY SCIENCE
Username:mingelman-sundberg
Elected:2017
Homepage: http://www.ki.se/fyfa



Present and Previous Positions
  • Positions at Karolinska Institutet:
    • Research Assistant in Physiological Chemistry 1976-1977
    • Lecturer in Physiological Chemistry 1977-1987 (appointed 1982)
    • Acting Professor of Physiological Chemistry 1987-1996
    • Professor of Molecular Toxicology 1996-present

Fields of Scholarship
  • Biochemistry
  • Molecular biology
  • Pharmacology
  • Pharmcogenetics
  • Genetics
  • Epigenetics
  • Drug metabolism
  • Adverse drug reactions

Honours and Awards
  • More than 440 original papers, 25,586 citations (ISI), 35 700 in Google Scholar and an h-factor of 84 (ISI) or 100 (Google Scholar)
  • Ranked as the 3rd "highest impact" researcher of 4,000 in the field of drug metabolism (cytochrome.net) and one of the world's most cited authors within the category Pharmacology (http://isihighlycited.com) and assigned “Highly Cited Researcher for 2015 and 2016 by Thomson & Reuters (http://www.highlycited.com)
  • Categorized by Thomson Reuters as one of the World’s Most Influential Scientific Minds (http://sciencewatch.com/sites/sw/files/sw-article/media/worlds-most-influential-scientific-minds-2014.pdf) based on recent (2002-2012) citations from highly ranked papers. (Top 1 % cited in the field of pharmacology)
  • Awards include The Svedberg Price, The Swedish Society for Biochemistry and Molecular Biology 1989; Honorary member of The American Society for Biochemistry and Molecular Biology 1990; The Gerhard B Zbinden Lecture Award, EUROTOX 1996; The ISSX European Scientific Achievement Award 2003; The Bengt Danielsson Prize, The Swedish Academy of Pharmaceutical Sciences 2008; The John G Warner Pfizer Lectureship in Pharmaceutical Sciences, USA 2011
  • Selected as Nauta Chair, Vrije University of Amsterdam, April, 2012
  • Received the ERC Advanced Grant (AdG) for the years 2017-2022

Imprint Privacy policy « This page (revision-9) was last updated on Tuesday, 12. September 2017, 13:11 by Kaiser Dana
  • operated by